H Joseph Reiser PhD

Chair Of The Board Of Directors

Country

United States

City

Villanova

Industry

Pharmaceuticals

Skill

Diabetes, Biotechnology, Drug Discovery, Lifesciences, Biopharmaceuticals, Drug Development, Pharmaceutical Industry, Clinical Development, Technology Transfer, Commercialization, Venture Capital, Oncology, Start-ups, Corporate Development, FDA, R&D, Licensing, Patents, Medical Devices, Mergers

Experience

Chair Of The Board Of Directors

Aclipse Therapeutics

2017-12 - Present · 8 yrs 10 mos

Greater Pittsburgh Area

CEO and Director

Mito Biopharm LLC

2015-6 - Present · 11 yrs 4 mos

Radnor, PA

Mito Biopharm is an emerging liver-centric therapeutic company with current focus on insulin-resistant diabetes and NASH. Deploying its leading platform technology in mitochondrial uncoupling, potential therapeutic approaches also include liver cancer and certain infectious diseases. Mito Biopharm's first lead product is expected to enter clinical testing in 2018.

Chairman of the Board of Directors

CureDM Group Holdings LLC

2015 - Present · 11 yrs

Wilmington, Delaware

Chairman of the Board

Complexa Inc.

2012-6 - 2017-9 · 5 yrs 4 mos

Pittsburgh, PA

Co-Founder and Chairman of the Board

Hylagenix LLC

2014 - 2017 · 3 yrs

Radnor, PA

Hylagenix was formed to bring novel orthopedic treatments to the US. Our approach is to identify gaps in US treatment therapies that can be satisfied with technologies already approved and commercialized in markets ex US. Therein, Hylagenix partners with foreign companies to expedite US regulatory acceptance and approval and realizing viable market options. Hylagenix is currently developing a first in class, single injection viscosupplement for knee and hip osteoarthritis exclusively licensed for the North American market.

Chairman of the Board

Cortendo AB

2014-9 - 2015-3 · 7 mos

Radnor, PA

Cortendo AB is now a Ireland-based biopharmaceutical company renamed StrongBridge BioPharmaceuticals and traded on NASDAQ National Market under the symbol SBBP.

CEO

Cortendo AB

2011-1 - 2014-9 · 3 yrs 9 mos

Radnor, PA; Gothenburg, Sweden

Cortendo is a commercially focussed, late stage biopharmaceutical company focussed on orphan drugs and endocrine diseases. www.cortendo.com.

CEO and Director

CureDM Group Holdings LLC

2008 - 2014 · 6 yrs

Wilmington, DE

CureDM is a clinical stage diabetes company focusing on novel treatments for type 1 and type 2 diabetes. Lead program is a human peptide impacting on islet neogenesis.